SRx Health Solutions Inc. (SRXH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

SRx Health Solutions Inc. (SRXH) Healthcare & Pipeline Overview

SRx Health Solutions Inc. delivers integrated specialty healthcare services throughout Canada, emphasizing customized solutions and patient-focused strategies. Operating in the drug manufacturing sector, SRx leverages technology to enhance wellness programs across all ten provinces, positioning itself as a comprehensive healthcare provider in a competitive market.

What Is the Investment Thesis for SRXH?

With a gross margin of 20.1% and a significant profit margin of 302.1%, SRx demonstrates strong profitability potential. Key growth catalysts include expanding its customized healthcare solutions across all Canadian provinces and leveraging technology to enhance patient outcomes. The company's commitment to patient-centric care positions it favorably in a market increasingly focused on personalized healthcare solutions. However, potential risks include navigating the complex regulatory landscape of the Canadian healthcare system and competition from larger, more established players in the healthcare services market.

Based on FMP financials and quantitative analysis

SRXH Key Highlights

Operates as an integrated healthcare services provider in Canada, offering comprehensive solutions across all ten provinces.

• Focuses on the specialty healthcare industry, providing customized services tailored to specific patient needs.
• Profit margin of 302.1% indicates strong profitability potential.
• Gross margin of 20.1% reflects efficient cost management in service delivery.
• Beta of 0.82 suggests lower volatility compared to the overall market.

Who Are SRXH's Competitors?

SRXH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are SRXH's Key Strengths?

Integrated healthcare service model.

• Customized solutions tailored to patient needs.
• Strong industry knowledge and expertise.
• Presence across all ten Canadian provinces.

What Are SRXH's Weaknesses?

Relatively small size with 11 employees.

• Limited brand recognition compared to larger competitors.
• Dependence on the Canadian healthcare system.
• Potential challenges in scaling operations.

What Could Drive SRXH Stock Higher?

Expansion into new regions within Canada to increase market share.

• Integration of new technologies to enhance service delivery and patient outcomes.
• Strategic partnerships with pharmaceutical companies to expand service offerings.

What Are the Key Risks for SRXH?

Negative return on equity (-97.8%) — the business is not currently generating profit on shareholder capital.

• Regulatory changes in the Canadian healthcare system impacting operations.
• Economic downturn affecting healthcare spending and patient demand.
• Competition from larger, more established healthcare providers.
• Technological disruptions rendering existing solutions obsolete.

What Are the Growth Opportunities for SRXH?

• Expansion Across Canadian Provinces: SRx Health Solutions Inc. has the opportunity to further expand its reach across all ten Canadian provinces. By establishing a stronger presence in underserved regions, SRx can tap into new markets and increase its patient base. The Canadian healthcare market is projected to reach $300 billion by 2028, offering substantial growth potential for SRx. This expansion can be achieved through strategic partnerships with local healthcare providers and targeted marketing campaigns.
• Technological Integration: Integrating advanced technologies, such as telehealth platforms and AI-driven diagnostic tools, can significantly enhance SRx's service offerings. The global telehealth market is expected to reach $55 billion by 2027, indicating a strong demand for remote healthcare solutions. By leveraging technology, SRx can improve patient access, reduce costs, and enhance the overall quality of care. This includes developing user-friendly mobile applications and secure data management systems.
• Customized Healthcare Solutions: SRx Health Solutions Inc.'s focus on customized healthcare solutions provides a significant competitive advantage. By tailoring its services to meet the specific needs of individual patients, SRx can improve patient outcomes and increase customer satisfaction. The personalized medicine market is projected to reach $2.4 billion by 2028, reflecting a growing demand for individualized treatment plans. This approach can be further enhanced by incorporating genetic testing and personalized medication management.
• Strategic Partnerships: Forming strategic partnerships with pharmaceutical companies and healthcare providers can expand SRx's service offerings and market reach. Collaborating with pharmaceutical companies can provide access to new medications and treatment protocols, while partnering with healthcare providers can enhance patient referrals and integrated care pathways. These partnerships can also facilitate the development of innovative healthcare solutions and improve the overall efficiency of the healthcare system.
• Focus on Preventative Care: Expanding its focus on preventative care can help SRx reduce healthcare costs and improve patient outcomes. By offering wellness programs, health screenings, and early intervention services, SRx can help patients manage their health proactively and prevent the onset of chronic diseases. The preventative healthcare market is projected to reach $600 billion by 2027, indicating a growing demand for proactive health management solutions. This includes offering educational resources and personalized health coaching.

What Are SRXH's Competitive Advantages?

• Integrated healthcare service model provides a comprehensive approach to patient care.
• Customized solutions cater to specific patient needs, enhancing customer satisfaction.
• Strong industry knowledge and technological integration improve service delivery.
• Established presence across all ten Canadian provinces provides a broad market reach.

What Does SRXH Do?

SRx Health Solutions Inc. is a Canadian integrated healthcare services provider dedicated to the specialty healthcare industry. The company was founded with the vision of delivering comprehensive, integrated, and customized healthcare services across all ten Canadian provinces. SRx Health Solutions combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians. Their services span a broad spectrum of specialty healthcare needs, ensuring that patients receive tailored care that addresses their specific conditions and requirements. SRx Health Solutions operates as a key player in the Canadian healthcare landscape, focusing on delivering patient-centric solutions. By integrating technology and deep industry expertise, SRx is committed to enhancing the quality and accessibility of specialty healthcare services across Canada. The company's comprehensive approach and dedication to patient wellness have established it as a trusted partner for healthcare providers and patients alike.

What Products and Services Does SRXH Offer?

• Provides integrated healthcare services in Canada.
• Offers customized specialty healthcare solutions.
• Operates across all ten Canadian provinces.
• Focuses on improving patient wellness through tailored strategies.
• Integrates industry knowledge and technology to enhance healthcare delivery.
• Offers comprehensive healthcare services to address diverse patient needs.

How Does SRXH Make Money?

• Generates revenue by providing customized healthcare services to patients.
• Partners with healthcare providers and pharmaceutical companies to expand service offerings.
• Focuses on delivering integrated healthcare solutions to improve patient outcomes.

What Industry Does SRXH Operate In?

SRx Health Solutions Inc. operates within the competitive Canadian healthcare services market, which is characterized by increasing demand for specialized and integrated healthcare solutions. The industry is driven by an aging population and a growing prevalence of chronic diseases. SRx competes with other healthcare providers and pharmaceutical companies, differentiating itself through its patient-centric approach and customized service offerings. The Canadian healthcare market is heavily regulated, with provincial governments playing a significant role in funding and oversight. SRx's ability to navigate this regulatory landscape and deliver cost-effective solutions will be critical to its success.

Who Are SRXH's Key Customers?

• Individual patients seeking specialty healthcare services.
• Healthcare providers looking to enhance their service offerings.
• Pharmaceutical companies seeking to partner on healthcare solutions.

SRx Health Solutions Inc. (SRXH) Valuation Context

Valued at $15.4M, SRXH is classified as a micro-cap stock. Relative to its peer group, SRXH's quantitative score of 40/100 is below the peer average of 52/100.

SRXH Revenue & Earnings Trend

In Q3 FY2026, SRXH generated $3.4M in top-line revenue, marking a sequential decrease of 1.4%. The company recorded a net loss of $4.1M, with diluted EPS of $-0.36. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare.

Company Profile

SRx Health Solutions Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in North Palm Beach, US. The company is led by CEO Kent Cunningham. SRXH has traded publicly since 2010.

Return on equity for SRx Health Solutions Inc. stands at -97.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -56.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 27.55 indicates the company holds enough short-term assets to cover its near-term obligations.

SRx Health Solutions Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.34 places it in the safe zone, indicating low near-term bankruptcy risk.

SRx Health Solutions Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 252.9% below estimates on average.

Over the past six months, SRx Health Solutions Inc. insiders filed 2 SEC Form 4 transactions — 0 sales and 2 purchases. On net that is roughly 248K shares acquired (about $129K) — insiders putting money in tends to read as conviction.

SRXH Financials

SRXH Latest News

SRXH Analyst Consensus

SRXH MoonshotScore

SRx Health Solutions Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources